
Jo Bhakdi
Founder / CEO - Quantgene
Quantgene saves lives through early detection, better prevention and more effective cures for all disease, starting with cancer. They have the fastest, most accurate COVID-19 test kit available on the market to date.
Jo leads a team of 22. He has raised $13 million to date and expects to end next year with more than 10,000 members.
Jo’s audience is engaged and numbers more than 20,000. He is happy to share your episode with his fans!
- Influencer
- Podcast Pro
- Entrepreneur
- 📍 Santa Monica, CA
read more
Let's talk about
- The future of medicine
- Biohacking
- Longevity
- Biotech
__
Jo Bhakdi is the founder of Quantgene, a company that combines precision genomics, AI and a new perspective on medicine to detect disease at early stages. Bhakdi galvanized a network of world-leading scientists and engineers to tackle computational and clinical challenges in DNA sequencing to build the future of medicine.
Quantgene is a platform that utilizes advanced machine learning to detect the 10 deadliest cancers at early stages with standard blood samples. It uses a novel ultra-high sensitivity diagnostics technology to detect tumor mutations in standard patient blood samples. Detecting cancer in stage 1 and 2 enables surgical removal of the tumors and avoids chemotherapy with significant effects on survival rates and costs.
Quantgene is effective for lung, breast, colorectal, pancreatic, liver, ovarian and prostate cancer as well as for melanoma, leukemia, non-hodgkin and hodgkin lymphoma.

BOOK NOW FOR your podcast
Jo Bhakdi
Founder / CEO - Quantgene
- Influencer
- Podcast Pro
- Entrepreneur
- 📍 Santa Monica, CA
Quantgene’s mission is to extend the healthy human lifespan by 10 years within the next 10 years, or more simply put: a decade within a decade.
To achieve this vision, Quantgene is striving to fix what’s broken in medicine, going well beyond a single pill or EMR update. The company is tackling conventional medicine from scratch and building a new system of Medical Intelligence™. They are innovating to effectively combine the full power of modern medical expertise, clinical-grade genetic and genomic intelligence and advanced data technology to prevent and detect diseases far earlier than is possible today.
Quantgene launched its first commercial offering, Serenity, earlier this year. The company has also acted quickly to stand-up next-day 99.9% accurate COVID-19 testing solutions for individuals and institutions.
Jo is founder and CEO of Quantgene. He leads a team of 22 that is growing quickly. He has raised $13 million to date and expects to end next year with more than 10,000 members.
Jo’s audience is engaged and numbers more than 20,000. He is happy to share your episode with his fans!
read more
Let's talk about
- The future of medicine
- Innovation
- Technology
- Biohacking
- Longevity
- Biotech
__
Jo Bhakdi is the founder of Quantgene, a company that combines precision genomics, AI and a new perspective on medicine to detect disease at early stages. Bhakdi galvanized a network of world-leading scientists and engineers to tackle computational and clinical challenges in DNA sequencing to build the future of medicine.
Quantgene is a platform that utilizes advanced machine learning to detect the 10 deadliest cancers at early stages with standard blood samples. It uses a novel ultra-high sensitivity diagnostics technology to detect tumor mutations in standard patient blood samples. Detecting cancer in stage 1 and 2 enables surgical removal of the tumors and avoids chemotherapy with significant effects on survival rates and costs.
Quantgene is effective for lung, breast, colorectal, pancreatic, liver, ovarian and prostate cancer as well as for melanoma, leukemia, non-hodgkin and hodgkin lymphoma.
BOOK NOW FOR your podcast
Jo Bhakdi
Founder / CEO - Quantgene
- 📍 Santa Monica, CA
- Influencer
- Entrepreneur
Quantgene’s mission is to extend the healthy human lifespan by 10 years within the next 10 years, or more simply put: a decade within a decade.
To achieve this vision, Quantgene is striving to fix what’s broken in medicine, going well beyond a single pill or EMR update. The company is tackling conventional medicine from scratch and building a new system of Medical Intelligence™. They are innovating to effectively combine the full power of modern medical expertise, clinical-grade genetic and genomic intelligence and advanced data technology to prevent and detect diseases far earlier than is possible today.
Quantgene launched its first commercial offering, Serenity, earlier this year. The company has also acted quickly to stand-up next-day 99.9% accurate COVID-19 testing solutions for individuals and institutions.
Jo is founder and CEO of Quantgene. He leads a team of 22 that is growing quickly. He has raised $13 million to date and expects to end next year with more than 10,000 members.
Jo’s audience is engaged and numbers more than 20,000. He is happy to share your episode with his fans!
read more
- The Future of Medicine
- Principles of Innovation
- Transformative Technology
- Biohacking and Quantified Health
- Data-Driven Longevity
- Going Beyond Standard Medicine
- Futurism and Progress
- Artificial Intelligence/ Machine Learning
- Early Cancer Detection and Treatment
__
Quantgene’s first product, Serenity, will fundamentally transform and improve the current paradigm of medicine by arming physicians with deep Medical Intelligence. Serenity adds millions of high-quality data points specific to each patient. By using patient evaluations, deep genetics, medical records and other data sources we gain a thorough and deep understanding of the patient’s health. Serenity’s foundation starts with a combination of:
- Hereditary clinical-grade genetics for deeper insights into the medical implications of germline variants
- Proprietary liquid biopsy system that utilizes somatic mutation detection in the blood to detect a number of deadly cancers at early stages including lung, breast, colorectal, pancreatic, liver, ovarian and prostate cancer as well as for melanoma, leukemia, non-hodgkin and hodgkin lymphoma.
Serenity augments the doctor’s insight with a system that guarantees real-time access to the highest-quality clinical intelligence to keep physicians ahead of all relevant data and keep patients better protected.

Quantgene – Targeting cancer molecule by molecule
Lunit’s detection method might seem an incredibly precise tool to detect cancer – Quantgene, however, takes this intricacy to a molecular level. Part of a new field of DNA-centric approaches to cancer detection, Quantgene ‘brings the two fields of cancer screening and genomics together,’ according to Founder and CEO Jo Bhakdi. Their algorithm analyzes cell-free DNA to determine your genetic disposition to cancer, whether you have cancer and in what part of the body. read more >>>
As seen in
August 10, 2020
June 22, 2020
LA Business Journal
June 2, 2020
Ask me
Why is conventional medicine and typical primary care failing to keep us healthy? |
Why do you think the promise of genetics and genomics has not yet been realized in medicine? What will it take for medicine to catch up to the potential of technology? |
What does the future of medicine look like? Is dramatic life extension in the near future? |
How is Quantgene working to detect cancer at the earliest stages in the blood? What is the technology/ mechanism that makes this possible? Why is early cancer detection so crucial to survival rates? |
How can young entrepreneurs best go about starting up a successful business? |
Podcast agent: Katie White
katie@kitcaster.com • (303) 514-8401